Webb Telescope gets the star treatment in new NASA documentary

The pages of Digital Trends are filled with breathtaking images of deep space captured by the James Webb Space Telescope, including the beautiful Cosmic Tornado, the gorgeous Ring Nebula, the incredible Carina Nebula, and a stunning spiral galaxy.
The Webb telescope — the most powerful ever built — launched in 2021 and has been scanning the far reaches of space ever since. Besides beaming back amazing infrared imagery, the telescope is also helping scientists to learn more about the universe's first stars and galaxies, the formation of numerous stars and planetary systems, and the origins of life itself, by exploring distant places with unprecedented clarity.
To celebrate the ongoing work of the Webb telescope, NASA has just released a documentary — Cosmic Dawn — that chronicles its more than two decades of development, highlighting the telescope's careful assembly, rigorous testing, and successful launch nearly five years ago.
Cosmic Dawn has a runtime of 96 minutes and is free to watch on YouTube. We've embedded it at the top of this page.
'At NASA, we're thrilled to share the untold story of our James Webb Space Telescope in our new film Cosmic Dawn, celebrating not just the discoveries, but the extraordinary people who made it all happen, for the benefit of humanity,' said Rebecca Sirmons, head of NASA+.
The documentary also offers viewers an inside look at the successes and setbacks experienced by the team at NASA's Goddard Space Flight Center in Greenbelt, Maryland — the birthplace of Webb. You'll also get to enjoy plenty of Webb's groundbreaking work, including remarkable images of the faint light of the first stars and galaxies that formed more than 13.5 billion years ago. The documentary also shares Webb's findings on black holes, planets in our solar system and far beyond, and plenty of other cosmic phenomena.
'Webb was a mission that was going to be spectacular whether that was good or bad — if it failed or was successful,' said video producer Sophia Roberts, who filmed some of the happenings prior to Webb's deployment.
Roberts added: 'It was always going to make history.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

41 minutes ago

• Yahoo

Investors should consider this growth stock… it's SpaceX's competition

Rocket Lab (NASDAQ:RKLB) is a US-listed growth stock that gives investors rare access to the commercial space sector. As a vertically integrated launch and space systems provider, Rocket Lab is often compared to SpaceX in its ambition and capabilities. But there's one crucial difference: you can actually buy shares in Rocket Lab, while SpaceX remains private. Rocket Lab delivers launch services, builds small and medium-class rockets, and manufactures spacecraft components for a range of commercial, government, and defense customers. With rapid revenue growth, an impressive order book, and expansion into new markets, Rocket Lab offers public market investors a way to participate in the booming space economy. It targets many of the same opportunities as its more famous, privately held peer. Rocket Lab and SpaceX operate in the same commercial space sector but differ significantly in scale, maturity, and valuation. Rocket Lab's market cap is currently $12.85bn, with trailing 12 months (TTM) revenue of approximately $460m. Despite strong growth — revenue nearly doubled from $240m in 2023 — Rocket Lab remains a smaller, earlier-stage player focused on small to medium launch vehicles and spacecraft manufacturing. Its valuation multiples are extremely high, with a forward price-to-sales ratio of 22.3 times, reflecting investor optimism. SpaceX, by contrast, is a far more mature private company valued at about $350bn. It's projected to generate $15.5bn in revenue in 2025. This is driven by its dominant Falcon 9 launch services and rapidly growing Starlink satellite internet business. SpaceX's valuation implies roughly a 22.5 times multiple on forward revenue. This is broadly in line with Rocket Lab. Focusing on Rocket Lab, the company is projected to deliver rapid revenue growth over the next several years, with estimates rising from $573m in 2025 to $889 in 2026, $1.2bn in 2027, and $1.69bn in 2028. This represents annual growth rates consistently above 30%, and even a jump of nearly 77% in 2030. However, the number of analysts providing forecasts declines sharply after 2027, dropping from 11–14 analysts in the near term to just two or one by 2028 and 2030. The one analyst projecting as far as 2030 sees $4bn in revenue for the year. I had the chance to buy Rocket Lab shares at $15 just two months ago. I missed out as unfortunately my attention had been diverted elsewhere. However, I found another entry point. And personally, I see this as an investment to hold for a very long period. The space industry is still in its early innings, with enormous potential as satellite launches, lunar missions, and in-orbit services become increasingly mainstream. And like any investment, there are risks. Rocket Lab remains loss-making. It's expected to turn a profit in 2026, when it will trade at 620 times earnings. And while this moderates to 140 times in 2027, it's still expensive and introduces plenty of execution risk. However, I certainly believe UK investors should consider this one. It could be a real winner going forward. The post Investors should consider this growth stock… it's SpaceX's competition appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool James Fox has positions in Rocket Lab. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio

Yahoo

an hour ago

• Yahoo

Forget 'biological age' tests — longevity experts are using an $800 under-the-radar blood test to measure aging in real-time

Doctors and scientists are using a blood plasma test to study longevity. The test measures proteins and can tell you about your organ health. This field of proteomics could one day help detect diseases like cancer before they start. Should you have that second cup of coffee? How about a little wine with dinner? And, is yogurt really your superfood? Scientists are getting closer to offering consumers a blood test that could help people make daily decisions about how to eat, drink, and sleep that are more perfectly tailored to their unique biology. The forthcoming tests could also help shape what are arguably far more important health decisions, assessing whether your brain is aging too fast, if your kidneys are OK, or if that supplement or drug you're taking is actually doing any good. It's called an organ age test, more officially (and scientifically) known as "proteomics" — and it's the next hot "biological age" marker that researchers are arguing could be better than all the rest. "If I could just get one clock right now, I'd want to get that clock, and I'd like to see it clinically available in older adults," cardiologist Eric Topol, author of the recent bestseller "Super Agers: An Evidence-Based Approach to Longevity," told Business Insider. Topol said armed with organ age test results, people could become more proactive stewards of their own health, before it's too late. "When we have all these layers of data, it's a whole new day for preventing the disease," Topol said. "You see the relationship with women's hormones. You see the relationship with food and alcohol. You don't ever get that with genes." A test like this isn't available to consumers just yet, but it's already being used by researchers at elite universities and high-end longevity clinics. They hope it can become a tool any doctor could use to assess patient health in the next few years. A startup called Vero, which was spun out of some foundational proteomics research at Stanford University, is hoping to beta test a proteomics product for consumers this year. "Knowing your oldest organ isn't the point; changing the trajectory is," Vero co-founder and CEO Paul Coletta told a crowd gathered at the Near Future Summit in Malibu, California, last month. Coletta told Business Insider Vero's not interested in doing "wealthcare." The company plans to make its test available to consumers for around $200 a pop, at scale. Their draw only requires one vial of blood. The big promise of proteomics is that it could be a more precise real-time tool for tracking important but subtle changes that emerge inside each of us as we age. Genetic testing can measure how our bodies are built, spotting vulnerabilities in a person's DNA that might predispose them to health issues. Standard clinical measurements like a person's weight, blood pressure, or cholesterol readings are a useful proxy for potential health issues. Then there are the increasingly popular "biological age" tests available to consumers at home. Most of those look at "epigenetic changes" — how environmental factors affect our gene expression. Proteomics does something different and new. It measures the product that our bodies make based on all those genetic and environmental inputs: proteins. It offers a live assessment of how your body is running, not just how it's programmed. If validated in the next few years, these tests could become key in early disease detection and prevention. They could help influence all kinds of medical decisions, from big ones like "What drugs should I take?" to little ones like "How does my body respond to caffeine or alcohol?" Some high-end longevity clinics are already forging ahead using proteomics to guide clinical recommendations, albeit cautiously. Dr. Evelyne Bischof, a longevity physician who treats patients worldwide, said she uses proteomic information to guide some of the lifestyle interventions she recommends to her patients. She may suggest a more polyphenol-rich diet to someone who seems to have high inflammation and neuroinflammation based on proteomic test results, or may even suggest they do a little more cognitive training, based on what proteomics says about how their brain is aging. Dr. Andrea Maier, a professor of medicine and functional aging at the National University of Singapore, told BI she uses this measurement all the time in her longevity clinics. For her, it's just a research tool, but if the results of her ongoing studies are decent, she hopes to be able to use it clinically in a few years' time. "We want to know what kind of 'ageotype' a person is, so what type of aging personality are you, not from a mental perspective, but from a physical perspective," Maier said. "It's really discovery at this moment in time, and at the edge of being clinically meaningful." "Once we have that validated tool, we will just add it to our routine testing and we can just tick the box and say, 'I also want to know if this person is a cardiac ager, or a brain ager, or a muscle ager' because now we have a sensitive parameter — protein — which can be added," Maier said. The two big-name proteomics tests are Olink and SOMAscan. For now, their high-end screening costs around $400-$800 per patient. "I'm losing lots of money at the moment because of proteomics for clinical research!" Maier said. Top aging researchers at Stanford and Harvard are pushing the field forward, racing to publish more novel insights about the human proteome. The latest findings from Harvard aging researcher Vadim Gladyshev's lab, published earlier this year, suggest that as we age, each person may even stand to benefit from a slightly different antiaging grocery list. To research this idea, Gladyshev looked at proteins in the blood of more than 50,000 people in the UK, all participants in the UK Biobank who are being regularly tested and studied to learn more about their long-term health. He tracked their daily habits and self-reported routines like diet, occupation, and prescriptions, comparing those details to how each patient's organs were aging. He discovered some surprising connections. Yogurt eating, generally speaking, tended to be associated with better intestinal aging but had relatively no benefit to the arteries. White wine drinking, on the other hand, seemed to potentially confer some small benefit to the arteries while wreaking havoc on the gut. "The main point is that people age in different ways in different organs, and therefore we need to find personalized interventions that would fit that particular person," Gladyshev told BI. "Through measuring proteins, you assess the age of different organs and you say, 'OK, this person is old in this artery.'" For now, there's too much noise in the data to do more. Dr. Pal Pacher, a senior investigator at the National Institute on Alcohol Abuse and Alcoholism who studies organ aging and injuries, told BI that proteomics is simply not ready for clinical use yet. There's just too much noise in the data. But he imagines a future where a more sophisticated protein clock could help link up which people may be most vulnerable to diseases like early cancer, kidney disease, and more. (A California-based proteomics company called Seer announced last weekend that it is partnering with Korea University to study whether proteomics can help more quickly diagnose cancer in young people in their 20s and 30s.) "How beautiful could it be in the future?" Maier said. "Instead of three hours of clinical investigation, I would have a tool which guides me much, much better, with more validity towards interventions." Read the original article on Business Insider

Yahoo

3 hours ago

• Yahoo

Strange signals detected from Antarctic ice seem to defy laws of physics. Scientists are searching for an answer

Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Scientists are trying to solve a decade-long mystery by determining the identity of anomalous signals detected from below ice in Antarctica. The strange radio waves emerged during a search for another unusual phenomenon: high-energy cosmic particles known as neutrinos. Arriving at Earth from the far reaches of the cosmos, neutrinos are often called 'ghostly' because they are extremely volatile, or vaporous, and can go through any kind of matter without changing. Over the past decade, researchers have conducted multiple experiments using vast expanses of water and ice that are designed to search for neutrinos, which could shed light on mysterious cosmic rays, the most highly energetic particles in the universe. One of these projects was NASA's Antarctic Impulsive Transient Antenna, or ANITA, experiment, which flew balloons carrying instruments above Antarctica between 2006 and 2016. It was during this hunt that ANITA picked up anomalous radio waves that didn't seem to be neutrinos. The signals came from below the horizon, suggesting they had passed through thousands of miles of rock before reaching the detector. But the radio waves should have been absorbed by the rock. The ANITA team believed these anomalous signals could not be explained by the current understanding of particle physics. Follow-up observations and analyses with other instruments, including one recently conducted by the Pierre Auger Observatory in Argentina, have not been able to find the same signals. The results of the Pierre Auger Collaboration were published in the journal Physical Review Letters in March. The origin of the anomalous signals remains unclear, said study coauthor Stephanie Wissel, associate professor of physics, astronomy and astrophysics at the Pennsylvania State University. 'Our new study indicates that such (signals) have not been seen by an experiment … like the Pierre Auger Observatory,' Wissel said. 'So, it does not indicate that there is new physics, but rather more information to add to the story.' Larger, more sensitive detectors may be able to solve the mystery, or ultimately prove whether the anomalous signals were a fluke, while continuing the search for enigmatic neutrinos and their sources, scientists say. Detecting neutrinos on Earth allows researchers to trace them back to their sources, which scientists believe are primarily cosmic rays that strike our planet's atmosphere. The most highly energetic particles in the universe, cosmic rays are made up mostly of protons or atomic nuclei, and they are unleashed across the universe because whatever produces them is such a powerful particle accelerator that it dwarfs the capabilities of the Large Hadron Collider. Neutrinos could help astronomers better understand cosmic rays and what launches them across the cosmos. But neutrinos are difficult to find because they have almost no mass and can pass through the most extreme environments, like stars and entire galaxies, unchanged. They do, however, interact with water and ice. ANITA was designed to search for the highest energy neutrinos in the universe, at higher energies than have yet been detected, said Justin Vandenbroucke, an associate professor of physics at the University of Wisconsin, Madison. The experiment's radio antennae search for a short pulse of radio waves produced when a neutrino collides with an atom in the Antarctic ice, leading to a shower of lower-energy particles, he said. During its flights, ANITA found high-energy fountains of particles coming from the ice, a kind of upside-down shower of cosmic rays. The detector is also sensitive to ultrahigh energy cosmic rays that rain down on Earth and create a radio burst that acts like a flashlight beam of radio waves. When ANITA watches a cosmic ray, the flashlight beam is really a burst of radio waves one-billionth of a second long that can be mapped like a wave to show how it reflects off the ice. Twice in their data from ANITA flights, the experiment's original team spotted signals coming up through the ice at a much sharper angle than ever predicted by any models, making it impossible to trace the signals to their original sources. 'The radio waves that we detected nearly a decade ago were at really steep angles, like 30 degrees below the surface of the ice,' Wissel said. Neutrinos can travel through a lot of matter, but not all the way through the Earth, Vandenbroucke said. 'They are expected to arrive from slightly below the horizon, where there is not much Earth for them to be absorbed,' he wrote in an email. 'The ANITA anomalous events are intriguing because they appear to come from well below the horizon, so the neutrinos would have to travel through much of the Earth. This is not possible according to the Standard Model of particle physics.' The Pierre Auger Collaboration, which includes hundreds of scientists around the world, analyzed more than a decade's worth of data to try to understand the anomalous signals detected by ANITA. The team also used their observatory to try to find the same signals. The Auger Observatory is a hybrid detector that uses two methods to find and study cosmic rays. One method relies on finding high-energy particles as they interact with water in tanks on Earth's surface, and the other tracks potential interactions with ultraviolet light high in our planet's atmosphere. 'The Auger Observatory uses a very different technique to observe ultrahigh energy cosmic ray air showers, using the secondary glow of charged particles as they traverse the atmosphere to determine the direction of the cosmic ray that initiated it,' said Peter Gorham, a professor of physics at the University of Hawaii at Mānoa. 'By using computer simulations of what such a shower of particles would look like if it had behaved like the ANITA anomalous events, they are able to generate a kind of template for similar events and then search their data to see if anything like that appears.' Gorham, who was not involved with the new research, designed the ANITA experiment and has conducted other research to understand more about the anomalous signals. While the Auger Observatory was designed to measure downward-going particle showers produced in the atmosphere by ultrahigh-energy cosmic rays, the team redesigned their data analysis to search for upward-going air showers, Vandenbroucke said. Vandenbroucke did not work on the new study, but he peer-reviewed it prior to publication. 'Auger has an enormous collecting area for such events, larger than ANITA,' he said. 'If the ANITA anomalous events are produced by any particle traveling through the Earth and then producing upward-going showers, then Auger should have detected many of them, and it did not.' A separate follow-up study using the IceCube Experiment, which has sensors embedded deep in the Antarctic ice, also searched for the anomalous signals. 'Because IceCube is very sensitive, if the ANITA anomalous events were neutrinos then we would have detected them,' wrote Vandenbroucke, who served as colead of the IceCube Neutrino Sources working group between 2019 and 2022. 'It's an interesting problem because we still don't actually have an explanation for what those anomalies are, but what we do know is that they're most likely not representing neutrinos,' Wissel said. Oddly enough, a different kind of neutrino, called a tau neutrino, is one hypothesis that some scientists have put forth as the cause of the anomalous signals. Tau neutrinos can regenerate. When they decay at high energies, they produce another tau neutrino, as well as a particle called a tau lepton — similar to an electron, but much heavier. But what makes the tau neutrino scenario very unlikely is the steepness of the angle connected to the signal, Wissel said. 'You expect all these tau neutrinos to be very, very close to the horizon, like maybe one to five degrees below the horizon,' Wissel said. 'These are 30 degrees below the horizon. There's just too much material. They really would actually lose quite a bit of energy and not be detectable.' At the end of the day, Gorham and the other scientists have no idea what the origin of the anomalous ANITA events are. So far, no interpretations match up with the signals, which is what keeps drawing scientists back to try to solve the mystery. The answer may be in sight, however. Wissel is also working on a new detector, the Payload for Ultra-High Energy Observations or PUEO, that will fly over Antarctica for a month beginning in December. Larger and 10 times more sensitive than ANITA, PUEO could reveal more information on what is causing the anomalous signals detected by ANITA, Wissel said. 'Right now, it's one of these long-standing mysteries,' Wissel said. 'I'm excited that when we fly PUEO, we'll have better sensitivity. In principle, we should be able to better understand these anomalies which will go a long way to understanding our backgrounds and ultimately detecting neutrinos in the future.' Gorham said that PUEO, an acronym that references the Hawaiian owl, should have the sensitivity to capture many anomalous signals and help scientists find an answer. 'Sometimes you just have to go back to the drawing board and really figure out what these things are,' Wissel said. 'The most likely scenario is that it's some mundane physics that can be explained, but we're sort of knocking on all the doors to try to figure out what those are.'